These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Approval of inhaled insulin in Europe and United States. Charlesworth B BMJ; 2006 Mar; 332(7543):730. PubMed ID: 16565143 [No Abstract] [Full Text] [Related]
6. Inhaled insulin is approved in Europe and United States. Lenzer J BMJ; 2006 Feb; 332(7537):321. PubMed ID: 16470037 [No Abstract] [Full Text] [Related]
7. First inhalable insulin approved. Katsnelson A Nat Biotechnol; 2006 Apr; 24(4):369-70. PubMed ID: 16601705 [No Abstract] [Full Text] [Related]
11. Identifying factors that affect patients' willingness to pay for inhaled insulin. Pinto SL; Holiday-Goodman M; Black CD; Lesch D Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826 [TBL] [Abstract][Full Text] [Related]
13. Inhaled insulin: gone with the wind? Mathieu C; Gale EA Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925 [No Abstract] [Full Text] [Related]
14. Inhaled insulin for the early detection of lung cancer. Lehrer S Med Hypotheses; 2008 Oct; 71(4):615-6. PubMed ID: 18602221 [No Abstract] [Full Text] [Related]
15. Another inhaled insulin casualty. Aldridge S Nat Biotechnol; 2008 Mar; 26(3):255. PubMed ID: 18327221 [No Abstract] [Full Text] [Related]
16. Verteporfin: restriction of indications: labelling change. A welcome move. A negative risk-benefit balance in neovascular forms of ARMD with "occult" lesions. Prescrire Int; 2008 Oct; 17(97):192. PubMed ID: 19536923 [No Abstract] [Full Text] [Related]
17. Telithromycin: visual disorders, myasthenia. Case fatalities: this macrolide has a negative risk-benefit balance; its use not justified. Prescrire Int; 2008 Apr; 17(94):66. PubMed ID: 18516818 [No Abstract] [Full Text] [Related]
18. Unknown risks of pharmacy-compounded drugs. Sasich LD; Sukkari SR J Am Osteopath Assoc; 2008 Feb; 108(2):86. PubMed ID: 18303067 [No Abstract] [Full Text] [Related]
19. Solostar pen for glargine and glulisine insulins: line extension. Less convenient than Innolet pen. Prescrire Int; 2008 Aug; 17(96):138-9. PubMed ID: 19484849 [No Abstract] [Full Text] [Related]